GIPR/CRE Luciferase Reporter HEK293 Cell Line

Catalog #
78589
$11,115 *
Size: 2 vials
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

GIPR/CRE Luciferase Reporter HEK293 Cell Line is an engineered HEK293 cell line expressing firefly luciferase under the control of cAMP response element (CRE), and human GIPR (Gastric Inhibitory Polypeptide receptor; NM_000164.4). Activation of GIPR in these cells can be monitored by measuring luciferase activity.

The functionality of the GIPR/CRE Luciferase Reporter HEK293 Cell Line was validated in dose-response assays using the agonists gastric inhibitory peptide (GIP), Tirzepatide, and Retatrutide. These agonists induce luciferase activity in a dose-dependent manner as depicted in Figure 1.

Created with BioRender.com

Figure 1. Illustration of the mechanism of action in the GIPR/CRE Luciferase Reporter HEK293 Cell Line.

Interested in screening and profiling inhibitors, blocking antibodies, or activators of GIPR without the need to purchase and license the cell line? Check out our Cell Signaling Pathway Screening.

Purchase of this cell line is for research purposes only; commercial use requires a separate license. View the full terms and conditions.

Synonyms
Gastric inhibitory polypeptide receptor, GIP-R, Glucose-dependent insulinotropic polypeptide receptor, GIPR, GIP responsive cell line, Tirzepatide responsive cell line, Retatrutide responsive cell line
Product Info
Storage and Usage
Citations
Host Cell Line
HEK293, Human Embryonic Kidney, epithelial-like cells, adherent
Supplied As
Each vial contains >1 x 106 cells in 1 ml of Cell Freezing Medium (BPS Bioscience #79796)
Materials Required But Not Supplied

Media Required for Cell Culture

Name Ordering Information
Thaw Medium 1 BPS Bioscience #60187
Growth Medium 1G BPS Bioscience #79544


Materials Required for Cellular Assay

Name Ordering Information
Gastric Inhibitory Peptide (GIP), human Genscript #RP10795
Tirzepatide hydrochloride MedChemExpress #HY-P1731
Retatrutide MedChemExpress #HY-P3506
Opti-MEM Reduced Serum Medium (Assay Medium) ThermoFisher #31985-070
ONE-Step™ Luciferase Assay System BPS Bioscience #60690
Luminometer  
UniProt #
P48546
Mycoplasma Testing

The cell line has been screened to confirm the absence of Mycoplasma species.

Background

The gastric inhibitory polypeptide receptor (GIPR), also known as glucose-dependent insulinotropic polypeptide receptor, belongs to the Class B1 G protein-coupled receptor (GPCR) family. GIPR is primarily found in the β-cells of the pancreas and serves as a receptor for the gastric inhibitory polypeptide (GIP) hormone. As one of the incretin hormones, GIP modulates glucose metabolism by stimulating the pancreatic β-cells to release insulin. Since GIPR/GLP-1R heterodimerization regulates GLP-1R signaling, dual agonists that bind both GIPR and GLP-1R have shown promising clinical efficacy for treating type II diabetes mellitus (T2DM) and obesity.

References

Yang B., et al., 2022 Molecular Metabolism 66: 101638